China Hearsay (Free subscription) | 11/04/2009
Swiss drugmaker Novartis AG is investing $1 billion to build the largest pharmaceutical research plant in China, emphasising the importance of developing markets for future growth. Novartis and other drugmakers are keen to tap into markets such as China as they face slowing growth and loss of exclusivity on key products, including the [...]
Market Watch (Free subscription) | 11/04/2009
TEL AVIV (MarketWatch) -- Novartis AG, the Basel health-care giant, said on Wednesday that it definitively agreed to acquire 85% of the closely held Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co. for about $125 million cash. The Chinese company produces vaccines targeting a number of viral and bacterial diseases, Novartis said. In 2008, Zhejiang Tianyuan doubled its net sales from...
MSNBC.com (Free subscription) | 10/29/2009
Swiss drug-maker Novartis AG says it will deliver about 30 million doses of swine flu vaccine to the United States by the end of November.
Physorg (Free subscription) | 10/29/2009
(AP) -- Swiss drugmaker Novartis AG said Thursday it is on track to meet its U.S. government order for swine flu vaccine, seeking to calm fears in recent weeks that shipments and vaccination programs may be delayed.
Fox News (Free subscription) | 10/29/2009
Swiss drugmaker Novartis AG is on track to deliver pandemic H1N1 swine flu vaccine to the United States in line with its commitments, despite low yields of the initial seed virus
Boston Herald (Free subscription) | 10/29/2009
LONDON - Swiss drug-maker Novartis AG says it will deliver about 30 million doses of swine flu vaccine to the United States by the end of November. The company says in...
Seattle Times (Free subscription) | 10/29/2009
Swiss drug-maker Novartis AG says it will deliver about 30 million doses of swine flu vaccine to the United States by the end of November.
Solar Energy News (Free subscription) | 10/28/2009
VACAVILLE, Calif.--( BUSINESS WIRE )--Novartis announced today the completion of the new 1 megawatt (MW) solar array near its Vacaville biopharmaceutical site. The announcement was made at a ceremony which celebrated the collective effort of state and local officials, employees and business partners in championing the approval, construction and completion of the $7 million dollar power plant. The...
The Sacramento Business Journal (Free subscription) | 10/28/2009
Swiss drug maker Novartis AG has completed a 1 megawatt solar array that will supply 20 percent of the electrical needs for its biopharmaceutical manufacturing facility in Vacaville, the company announced Wednesday. (NVS)
Market Watch (Free subscription) | 10/28/2009
FRANKFURT (MarketWatch) -- Swiss pharmaceutical company Novartis AG said Wednesday the medicine Ilaris has been approved in the European Union to treat adults and children with cryopyrin-associated periodic syndrome (CAPS), a rare life-long auto-inflammatory disease with debilitating symptoms. The accelerated E.U. decision follows approvals in the U.S. and Switzerland. Ilaris is the only medicine...
MarketIntelligenceCenter.com (Free subscription) | 10/27/2009
Novartis AG (NVS) appears to be on the move today and is now at $52.19, up $1.19 (2.34%) on volume of 507,316 shares traded. Over the last 52 weeks the stock has ranged from a low of $33.34 to a high of $52.51. Novartis AG stock has been showing support around $50.01 and resistance in the $52.63 range. Technical in...
AboutLawsuits.com (Free subscription) | 10/23/2009
A Montana jury has awarded $3.2 million to a woman who suffered debilitating jaw necrosis from Zometa, a bone strengthening drug prescribed to many cancer patients. The Zometa lawsuit was the first of about 550 cases to go to trial against Novartis Pharmaceuticals Corp. All of the claims involve similar allegations that the drug [...]
A Georgia Lawyer (Free subscription) | 10/23/2009
A Missoula jury on Wednesday awarded $3.2 million to a woman suing the maker of a bone-strengthening drug in a decision that could have a bearing on hundreds of cases against the company nationwide. Peggy L. Stevens, 57, of Missoula filed suit against Novartis Pharmaceuticals Corp., alleging the company should have disclosed health risks associated with the bone-strengthening drug called Zometa. Stevens...
Examiner (Free subscription) | 10/22/2009
Drug maker Novartis AG has posted a 1 percent increase in third-quarter net profit driven by strong sales from its pharmaceuticals division.
Miami Herald (Free subscription) | 10/22/2009
Drug maker Novartis AG posted Thursday a 1 percent increase in third-quarter net profit on strong sales of pharmaceuticals, such as its new Afinitor drug against kidney cancer, and raised its full-year outlook after the approval of its swine flu vaccines.
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNINg
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS/ Two days later I was BLIND Use Google and enter EPOCRATES...
The 2 latest articles published by users on Novartis AG :
obi jo | 07/27/2009
http://benkazie.wordpress.com/2009/07/27/quick-post-panel-urges-fda-to-expedite-swine-flu-vaccine-approval/ US Global health officials are scrambling to try to prevent the spread of the H1N1 swine flu virus, with US officials moving Thursday with a recommendation that the Food and Drug Administration approve or license a vaccine. A federal advisory panel said the FDA should move ahead to approve or
ravjen | 06/14/2009
Swine flu vaccine successfully produced weeks ahead of expectations of the Swiss pharmaceutical company Novartis AG . The vaccine was made in cells, rather than grown in eggs as is usually the case with vaccines.
Videos